|
|
||||||||
Biology of Reproduction, Vol 25, 15-28, Copyright © 1981 by Society for the Study of Reproduction
1 Veterinary Resources Branch, Division of Research Services,
National Institutes of Health,
Bethesda, Maryland 20205 Reproductive behavior and ovarian and endocrine relationships were studied in the cat during
and following a controlled mating regimen during estrus (n = 12) and an estrous period without
mating (n = 5). Ovulation was confirmed laparoscopically only in animals experiencing coitus.
Average (± SEM) duration of estrus and follicle numbers were similar (P>0.05) in ovulating (5.8 ±
0.2 days; 5.0 ± 0.5 follicles) and nonovulating (6.4 ± 0.6 days; 5.2 ± 1.0 follicles) queens. Duration
of the luteal and interestrous interval in ovulating cats was 38.2 ± 2.8 and 50.3 ± 2.7 days, respectively. Following repeated mating, 86.6% of vesicular follicles detected on Day 1 of estrus ovulated, resulting in a mean CL number of 4.3 ± 0.5. Mean serum estradiol-17 In unmated queens the mean serum estradiol-17 These data interrelate events of the reproductive cycle of the cat and suggest that 1) the mated
estrual queen exhibits a gradual decline in pituitary LH response after repeated coitus; 2) "coitusto-ovulation" interval is an inappropriate parameter for this species since neither single nor multiple copulation always ensures an LH response and, thus, ovulation; 3) although follicular activity is
greatest during estrus, periods of follicle growth and regression appear to occur continually even
during the luteal phase.
concentration was variable but generally greater than 20 pg/ml during
estrus in both mated and unmated queens. In the former group repeated matings elicited an LH
response during the first 2 days of estrus (Days 1 and 2) in 10 of 12 queens. Two cats mated 3
times daily failed to produce an LH response until Day 2. On Day 1 mean LH rose from 4.3 ng/ml
(0 h) to 50.4, 74.1, and 25.8 ng/ml at 4, 8, and 14 h, respectively. On Day 2, average LH changed
from 10.3 ng/ml (0 h) to 27.7, 23.4, and 9.6 ng/ml at 4, 8, and 14 h, respectively. Generally no
further increase in LH response was detected even though queens continued to mate. The initial
rise in mean serum progesterone occurred on the morning of Day 4 or
64-68 h after the first
detected LH peak. In five of 12 cases, ovulation was completed within 48-52 h of the LH peak.
In the remaining seven cats, ovulation occurred 52 h or more after the LH peak but was completed
in all animals by midafternoon on Day 5. Data from individual cats during estrus were similar to
the average results; however, dramatic temporal fluctuations in steroid hormones, particularly
estradiol-17
were often observed. Vesicular follicles were observed on the ovaries of individual
cats during all stages of the luteal and interestrous interval. During these periods elevations in
serum estradiol-17
above basal concentrations were occasionally detected particularly following
the end of the luteal phase. During the latter phase, mean CL diameter increased gradually with
elevations in serum progesterone; however, regression of visible luteal tissue was gradual with CL
remnants remaining visible through the end of the interestrous interval.
profile during and after estrus was similar to
the ovulating group. LH and progesterone were sustained at basal concentrations throughout these
periods.
Note:
ACKNOWLEDGMENTS
The authors thank Dr. G. D. Niswender for supplying estradiol-17
(#244) and progesterone (#337)
antiserum, Dr. J. J. Reeves for providing the bovine
antiserum, and Dr. L. E. Reichert for supplying the
ovine LH and canine pituitary standard. We are particularly indebted to P. Schmidt, S. Guthrie, and A.
Stewart for their invaluable technical expertise, and
J. Koeser for assisting in preparation of the manuscript.
Portions of this work were conducted at the Institute of Comparative Medicine, Baylor College of
Medicine, Houston, TX, with the partial financial
support of the Ralston Purina Co., St. Louis, MO.
Names of commercial manufacturers and trade names
are provided for identification purposes only and inclusion does not imply endorsement by the National
Institutes of Health, U.S. Public Health Service of the
U.S. Department of Health and Human Services.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |